Isoxazole derivatives and methods of treating nitric oxide...

Details Isoxazole derivatives and methods of treating nitric oxide... Isoxazole derivatives and methods of treating nitric oxide...

2007-11-06

2007-11-06

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

11093182

ABSTRACT:
A series of isoxazole derivatives and methods of suppressing, inhibiting, or preventing disorders mediated by nitric oxide (NO) and/or proinflammatory cytokines, such as TNF-α (tumor necrosis factor alpha), IL-1 (interlukin-1), and IL-6, are described.

REFERENCES:
patent: 5059614 (1991-10-01), Lepage et al.
patent: 6727272 (2004-04-01), Lee et al.
patent: WO-2004/006834 (2004-01-01), None
CA Registry No. 717866-68-7, entry date into the Registry file on STN is Jul. 28, 2004.
CA Registry No. 717858-34-9, entry date into the Registry file on STN is Jul. 28, 2004.
CA Registry No. 688051-07-2, entry date into the Registry file on STN is Jun. 1, 2004.
Svab et al., CA 100:82623, 1984.
Svab et al., Cesko-Slovenska Farmacie, (1983), 32(9-10), pp. 316-322.
Miljkovic, Dj. et al., “Leflunomide Inhibits Activation of Inducible Nitric Oxide Synthase in Rat Astrocytes,”Brain Research, 2001, 889, 331-338.

Affiliated with

Also associated with

Rating

Isoxazole derivatives and methods of treating nitric oxide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoxazole derivatives and methods of treating nitric oxide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole derivatives and methods of treating nitric oxide... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3860500